glp-1 eating disorders Experts express alarm that RAs may trigger or worsen disorders. But is there any role they might play in binge eating disorder? And how can clinicians protect patients from risk? New Insight: GLP‑1 medications—long used

Kesavan S, Akim AM, Chaudry G, Ranneh YK

FIGURE 1 The prevalence of DED, which surged to as high as 61.0% during the COVID-19 pandemic (Ji et al., 2023), underscores the influence of increased exposure to visual display terminals and widespread mask usage during the pandemic, which likely exacerbated the condition by decreasing blink frequency and increasing thermal air currents over the ocular area, thus enhancing tear evaporation rates (Uwimana et al., 2022

10.1007/s12035-014-8825-3 Mol

Estos pacientes lograron un sueo ms continuo y eficiente bajo DSIP, aunque en otros estudios los efectos fueron menos consistentes

No, swollen lymph nodes (lymphadenopathy) are not listed as a recognised side effect in the UK regulatory data for GLP-1 receptor agonists

Inflammatory Bowel Disease (IBD) : IBD is another common cause of vitamin B12 deficiency in dogs